Rules, radiopharmaceuticals and a passion for compliance

At SAM Nordic, we care about doing things right — not just in the warehouse or on the road, but in every regulatory detail, every safety report, and every interaction with health authorities across the Nordics and Baltics. That work requires someone who genuinely enjoys the rulebook — and at SAM Nordic, we have exactly that.

That person is Jasmina, based in Helsinki, Finland. A self-described city girl with a love for travel — both city breaks and beach destinations — she brings the same curiosity to her work as she does to exploring new places. Before joining SAM Nordic, she spent a few years as a consultant in the pharmaceutical industry, picking up knowledge and experience across different areas of business.

"It was a great way to gain competence and understanding of how different parts of this industry work," she says.

Today, Jasmina's role sits at the intersection of regulatory affairs and pharmacovigilance — two areas that, as she puts it, are not everyone's idea of fun.
"I'm a rule interpreter," she says. "Regulatory guidelines are not exactly everyone's idea of a page-turner — but I genuinely enjoy them. And I think that shows in the work." 

One framework, eight countries
Working with radiopharmaceuticals across the Nordic and Baltic countries might sound straightforward — after all, EU legislation provides a common framework. But as Jasmina explains, the details matter enormously.

"The regulatory framework is quite harmonized through EU legislation, but the differences are found in national implementation," she says. "There are differences in radiation safety requirements, licensing processes for handling radioactive materials, and interactions with national authorities. There can also be differences in hospital practices and expectations for documentation."

In other words, knowing the rules is one thing. Knowing how each country applies them is another skill entirely — and one that Jasmina has built up carefully over time.

Staying ahead of the curve
In regulatory affairs, standing still is not an option. Guidelines change, authorities update their requirements, and the industry evolves. Jasmina's approach is systematic and proactive.

"I regularly monitor updates from authorities such as EMA and national agencies, subscribe to industry newsletters and professional networks, and participate in training sessions and webinars," she says. "But I also make it a point to discuss regulatory changes with colleagues — to understand their practical impact on our processes, not just the theory."

That last point matters. Regulatory knowledge only becomes useful when it is translated into practice — and that requires both expertise and collaboration.

From approval to patient
How long does it take to launch a radiopharmaceutical product in the Nordic and Baltic region? The honest answer, Jasmina says, is that it depends.

"If everything runs smoothly, we can make a launch happen in a few months. But the process can vary from a few months to around a year, depending on the country, reimbursement requirements, and the product's radiological and supply chain needs."

Coordinating market access, radiation permits, logistics and local hospital readiness across multiple countries at the same time is genuinely complex — and it is precisely the kind of challenge where SAM Nordic's experience and local knowledge make a real difference.

The surprising reality of radioactive medicine
Ask Jasmina what surprises people most about her field, and her answer challenges a common assumption.

"People often think the biggest challenge is radioactivity itself," she says. "But the reality is that short half-lives, manufacturing timing, and delivery logistics are often just as critical as science."

She is also quick to highlight something that rarely makes the headlines: how precise and targeted modern radiopharmaceutical treatments are.

"It's also surprising how targeted the treatment with radioactive products can be — minimizing the exposure of radiation to the rest of the body."

The art of paying attention
Pharmacovigilance — the science of monitoring the safety of medicines — demands a particular kind of mindset. Jasmina describes it well.

"Attention to detail is very important, because safety information can come from many different sources, and even small details may be critical for identifying potential safety issues," she says. "But strong communication and cross-functional collaboration skills are just as important. Pharmacovigilance sits at the intersection of patient safety, regulatory affairs, medical affairs, and quality."

It is, she adds with a smile, a great match for her.

Why SAM Nordic?
Regulatory expertise is only valuable if it translates into real outcomes — for the process, the product, and ultimately the patient. Ask Jasmina what sets SAM Nordic apart, and the answer reflects exactly that.

"We combine regulatory and pharmacovigilance expertise with a strong quality mindset, ensuring both compliance and patient safety. We are detail-oriented and committed to giving the best possible outcome for the process, the product and the patients — while making sure the regulatory requirements are met all the time."

In a field where the details can make all the difference, that is exactly the kind of passion for compliance you want on your side.

---

Stay updated - follow us on LinkedIn